Microfluidics applications are greatly diversifying, creating new opportunities

Extracted from:
Status of the Microfluidics Industry, Yole Développement, 2019


  • Diversification of microfluidics has led to burgening new application & market growth.
  • Acquisition wave continues, leading to an impressively rapid structuration.
  • Microfluidic technologies are penetrating various flourishing applications, where the challenges are big but the potential is significant.
  • Presentation: “Status of the Microfluidics Industry: the lure of microfluidic devices high volume production “ on October 9 at Lab-on-Chip World & Microfluidics Congress - Full agenda


LYON, France – September 30, 2019: Microfluidics is now a mature technology, and today the identified number of companies developing microfluidic-based solutions worldwide far surpasses a thousand, including myriad opportunistic startups, and the applications are end-less. Under this dynamic context, the market research and strategy consulting company, Yole Développement (Yole) estimates, the microfluidic products market reached US$8.7 billion in 2018, and will grow at a 11.7% CAGR between 2019 and 2024, reaching US$17.4 billion.
“The two principal applications are still PoC testing and pharmaceutical/ life science research, including sequencing, genomics, and proteomics”, details Sébastien Clerc, Technology & Market Analyst at Yole. “However, dynamics per application are evolving...”
Yole announces today its new microfluidics report, Status of the Microfluidics Industry. This new analysis provides an complete overview of the past two years, present and future for microfluidic devices and products. In order to get a better understanding of the value and its distribution all along the supply chain, this report covers both the microfluidic device and microfluidic-based product markets. It delivers a detailed analysis of every microfluidics application, with an overview of the main players per application. This report also analyzes microfluidic players’ dynamics and ranking, and highlights the latest industry trends, strategic moves, and business models’ evolutions. Innovative technologies, materials and manufacturing processes are also well described in this new analysis. What is the status of the microfluidics industry? Yole’s analysts offer you today a snapshot of this technology and associated markets.

Under its new technology & market analysis, Status of the Microfluidics Industry, Yole’s analysts propose a relevant study focused on the microfluidic technologies and the related applications and market segments. According to this report, PoC devices are increasing in complexity and integrating more and smart combinations of materials among glass, silicon and polymer, to offer additional functions. Analysts also identified high-end applications increasingly using polymer when possible, in order to decrease costs. Glass and silicon have a large share in these applications, especially in sequencing, explains Yole’s team. However these semiconductor materials are increasingly integrated at the heart of complex plastic cartridges. “This is also the case in drug delivery – even though most devices are made of glass and silicon today, we may soon observe the entry of polymer devices”, comments Sébastien Clerc from Yole. Overall, thanks to increased commercial adoption, all three materials are growing nicely.

Microfluidics is increasingly appealing to many large players, the leaders in various technology sectors. Several of them have recently decided to enter or strengthen their position in the microfluidics market, which reflects the attractiveness of this dynamic field. This is a good opportunity for these companies to find new growth areas where they can leverage their core expertise. A good example is the growing presence of SCHOTT in the domain of micro-structured devices for diagnostics and life sciences. Its recent acquisition of Minifab enables the glass manufacturer to complement its existing capabilities to serve these applications well.
Sébastien had the opportunity to interview Greg Wolters, Head of SCHOTT SBF Diagnostics and Christian Jabschinsky, Head of SCHOTT NEXTERION®. They invite you to discover their discussion today on i-Micronews.com.

Emerging applications, in particular within the biotechnology field, can benefit from the improvement of microfluidic technologies and innovations. “Today, academics and researchers are the main users of such technologies in biotech, but we have begun seeing an increased adoption from pharmaceutical companies, CRO , and industrial biotech companies”, explains Asma Siari, PhD. Technology & Market Analyst at Yole.“For example, cell line development, single-cell isolation/analysis, as well as cell-gene therapies and gene editing, are all applications where microfluidics have a role to play.”
In particular, microfluidics is receiving enthusiastic response from single-cell isolation, where there are already several successful commercialized technologies. The other applications mentioned above are steadily emerging, and it is time for innovative microfluidic companies to take the opportunity to solve the issues linked to integration, automation, throughput increase, etc. Indeed, most solutions used today are expensive and low-throughput, and thus prone to human error due to manual operations.

In its microfluidic report, Yole proposes a detailed description of the challenges these fields face. The company points out how microfluidic technologies, for example droplet microfluidics, can address the bottlenecks and forge new possibilities…
A detailed description of the report, Status of the Microfluidics Industry is available on i-Micronews.com.

In addition, these results will be detailed during a presentation proposed by Yole at Lab-on-a-Chip and Microfluidics World Congress (Coronado Island, California – October 7 to 9, 2019):
-  Title of the presentation: Status of the Microfluidics Industry: The Lure of Microfluidic Devices High Volume Production
-  Date: October 9 at 10:30 PM
-  Location: during co-located conference, titled The Companies, Emerging Technologies & Commercialization Track "B".
-  Speaker: Sébastien Clerc, Technology & Market Analyst, Microfluidics & Medical Technologies, Yole Développement
Full program on i-Micronews.com.

Make sure to collect all presentations that are regularly posted on i-Micronews.com. Stay tuned!

CAGR: Compound Annual Growth Rate
PoC : Point of Care
CRO: Contract Research Organization

Connect with us

Newsletter subscription

About Yole Développement